Isolation, structural elucidation and antibacterial activity of the chemical constituents of Scaevola spinescens.
Date
2009
Authors
Mejin, Michele
Editors
Advisors
Pyke, Simon Matthew
Semple, Susan
Semple, Susan
Journal Title
Journal ISSN
Volume Title
Type:
Thesis
Citation
Statement of Responsibility
Conference Name
Abstract
Scaevola spinescens, an Australian indigenous plant has been used by Australian Aboriginal
people in their traditional medicines for treating colds, stomach ache, urinary problems and
pain in the alimentary tract, skin rashes, boils and sores. An infusion of leaves and twigs of
Scaevola spinescens and Codonocarpus cotinifolius has been reputed to cure cancer.
Therefore, this plant has been deemed desirable for investigation to identify possible active
compounds that contribute to these medicinal therapies used by the Aboriginal people.
Previous work has shown that coumarins, terpenoids, iridoids and flavonoids are the classes of compounds isolated from Scaevola spinescens. So far, chemical constituents of Scaevola spinescens have only been isolated from hexane and methanol fractions. One of the aims of
this research was to isolate more of the chemical constituents of Scaevola spinescens.
Therefore in this research, the ethyl acetate and aqueous fractions were also included to
broaden the range of compounds being isolated.
In this research, eleven compounds have been isolated from Scaevola spinescens. Five of the
isolated compounds are known – myricadiol, 20-epi-ursolic acid, decursinol, luteolin-7-Oglucoside,
and 2-deoxy-D-chiro-inositol. A novel compound identified as 18-epi-taraxerol has
been isolated from Scaevola spinescens in this study. The structures of these compounds were
determined using 1D and 2D NMR, UV-Visible spectroscopy, FTIR and high-resolution mass
spectrometry. The structures of the five remaining compounds are yet to be determined.
The antiviral, antitumor and antibacterial activity of Scaevola spinescens extracts has been
previously investigated. Previous work has shown that Scaevola spinescens was active against
human cytomegalovirus (HCMV). However, previous work done on the antitumor activity of
Scaevola spinescens was inconclusive. Previous work done on the antibacterial activity
showed that some of the methanol fractions from Scaevola spinescens might contain
antibacterial agents. However, these active compounds that contribute to the antibacterial
activity were yet to be identified.
In this work, the organic (hexane, ethyl acetate and methanol) and aqueous crude extracts of
Scaevola spinescens were screened for antibacterial activity against Gram-positive
(Staphylococcus aureus ATCC 25923 and Streptococcus pyogenes ATCC 10389) and Gramnegative
(Pseudomonas aeruginosa ATCC 27853 and Escherichia coli ATCC 25922) bacteria
using a broth micro-dilution assay to determine minimum inhibitory concentration (MIC) and
minimum bactericidal concentration (MBC).
The hexane, ethyl acetate and methanol crude extracts were found to have antibacterial
activity against Gram-positive bacteria specifically Streptococcus pyogenes while the aqueous
fractions showed significant antibacterial activity against Staphylococcus aureus. No
antibacterial activity was observed against Gram-negative bacteria.
A promising antibacterial activity was observed on one of the isolated compounds, 20-epiursolic
acid. This compound showed good antibacterial activity against Streptococcus
pyogenes and Staphylococcus aureus with MIC in the range 1.87 to 7.5 μg/ml.
The research presented within this thesis shows that 20-epi-ursolic acid isolated from Scaevola
spinescens might be a potential candidate as an antibacterial agent. This is supported by the
results obtained from preliminary antibacterial screening on the organic and aqueous crude
extracts.
School/Discipline
School of Chemistry and Physics
Dissertation Note
Thesis (M.Sc.) - University of Adelaide, School of Chemistry and Physics, 2009.
Provenance
Copyright material removed from digital thesis. See print copy in University of Adelaide Library for full text.